Emad, Amin http://orcid.org/0000-0003-0846-4275
Ray, Tania
Jensen, Tor W.
Parat, Meera
Natrajan, Rachael
Sinha, Saurabh
Ray, Partha S.
Funding for this research was provided by:
National Cancer Institute (261201300028C-0-0-1)
National Institute of General Medical Sciences (1U54GM114838)
Warren H. and Clara Cole Foundation (Career Development Award)
Carle Foundation Translational Cancer Research Fund
Article History
Received: 16 October 2019
Accepted: 1 June 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: The authors declare the following conflicts of interest: AE, none; TR, employee, Onconostic Technologies, Inc.; TWJ, consultant, Onconostic Technologies, Inc.; MP, none; RN, none; SS, none; PSR, patents related to FOXC1 and FOXA1 in cancer, stock ownership in and employee, Onconostic Technologies, Inc.